Çмú´ëȸ ÀϽà ¹× Àå¼Ò

  • ÀÏ ½Ã : 2005³â 4¿ù 21ÀÏ(¸ñ) ~ 22ÀÏ(±Ý)
  • Àå ¼Ò : ·Ôµ¥È£ÅÚ ¼Ò°øµ¿ÁöÁ¡

    2005³â 4¿ù 21ÀÏ(¸ñ)
    09:00-10:20 ±¸¿¬ (1)  °©»ó¼±(I) 1-8
                  ÁÂÀå/ÁÂÀ庸-À̱¤¿ì/À¯¸íÈñ
    ±¸¿¬ (2)  ½Ã»óÇϺÎ-³úÇϼöü 9-15
                  ÁÂÀå/ÁÂÀ庸-±è¼º¿¬/±è°æÁø
    10:20-10:40 Coffee Break
    10:40-12:10 Symposium (1) °ñ´ë»ç                                      ÁÂÀå/ÁÂÀ庸-±è±â¼ö/Àӽ±æ
    Update & Debate in Management of osteoclast activating disease

    (1) Mechanism of Bone metastasis and management
    Toshiyuki Yoneda (Osaka University, Japan)

    (2) New therapy in hyperparathyroidism : Surgical vs Medical
    ¹Î¿ë±â (¼º±Õ°üÀÇ´ë)

    (3) New strategy in Long term management of osteoporosis:
          bone density vs bone quality
    À±Çö±¸ (¼º±Õ°üÀÇ´ë)
    12:10-13:00 Plenary Lecture                                                                     ÁÂÀå-Á¶º¸¿¬
    Regulation of the expression of a calcineurin inhibitors, ZAKI-4¥á by thyroid hormone through activation of PI3K-Akt/PKB-mTOR signaling cascade
                                                            Hisao Seo (Nagoya University, Japan)
    13:00-14:00 Luncheon Lecture  Neurontin satellite symposium(April21 2005)
    13:00~ 13:05Introduction¼­¿ïÀÇ´ë ÀÌÈ«±Ô
    13:05~ 13:25Overview of the diagnosis of DPN°¡Å縯ÀÇ´ë À±°ÇÈ£
    13:25~ 13:45Various strategy of DPN treatment ÀüºÏÀÇ´ë ¹Úż±
    13:45~ 13:55Q&A
    14:00-14:40 Special Lecture                                                                     ÁÂÀå-±è¿µ¼³
    TESTOSTERONE AND AGING IN MALES
                                John Morley (Saint Louis University Medical Center, USA)
    14:40-16:10 Symposium (2) ½Å°æ³»ºÐºñ
                  ÁÂÀå/ÁÂÀ庸-±è¼±¿ì/±è¼º¿î
    ¼ºÀåÈ£¸£¸ó °úÀ× È¤Àº °áÇÌÀÇ °ü¸®

    (1) Role of GH in Metabolism
    ±èµ¿¼± (ÇѾçÀÇ´ë)

    (2) ¼ºÀåÈ£¸£¸ó °áÇÌÁõÀÇ Áø´Ü(¼ºÀåÈ£¸£¸ó
         Àڱذ˻縦 Áß½ÉÀ¸·Î ÇÑ °íÂû)
    ±èµÎ¸¸ (ÇѸ²ÀÇ´ë)

    (3) ¸»´Üºñ´ëÁõ Ä¡·áÀÇ Àü¸Á ¹× ¹®Á¦Á¡
    ³²¹®¼® (ÀÎÇÏÀÇ´ë)
    Symposium (3) »ý½Ä³»ºÐºñ
                  ÁÂÀå/ÁÂÀ庸-¹ÚÇü¹«/ÃÖ¿õȯ
    °»³â±â¿Í È£¸£¸ó ¿ä¹ý

    (1) Current status of HRT after WHI
         (Pros)
    À±º´±¸ (¼º±Õ°üÀÇ´ë)

    (2) Current status of HRT after WHI
         (Cons)
    ½ÅÂù¼ö (¼­¿ïÀÇ´ë)

    (3) Àú¿ë·® ¹× ±Ø¼Ò¿ë·® ¿©¼ºÈ£¸£¸ó
         ´ëü¿ä¹ý
    À̺´¼® (¿¬¼¼ÀÇ´ë)
    16:10-16:30 Coffee Break and Poster Session
    16:30-17:50 ±¸¿¬ (3)  ºÎ°©»ó¼± ¹× °ñ´ë»ç(I) 16-22
                  ÁÂÀå/ÁÂÀ庸-ÇÑÀαÇ/ÃÖÁ¦¿ë
    ±¸¿¬ (4)  °©»ó¼± ¹× °ñ´ë»ç(¥±) 23-30
                 ÁÂÀå/ÁÂÀ庸-±Ã¼º¼ö, Çѱâ¿Á
    2005³â 4¿ù 22ÀÏ(±Ý)
    08:00-08:50 Satellite symposium (I)                                                           ÁÂÀå - ±è¼±¿ì
    Clinical implication of lipid management in diabetic patients
    1. How much should we lower cholesterol in diabetic patients?
    - Lower the Better¸¦ Áß½ÉÀ¸·Î -
    ¿µ³²ÀÇ´ë ÀÌÇü¿ì
    2. Role of statin in lipid control ºÎ»êÀÇ´ë ±èÀÎÁÖ
    09:00-10:20 ±¸¿¬ (5)  °ñ´ë»ç(¥²) 31-38
                   ÁÂÀå/ÁÂÀ庸-±èº¸¿Ï/°­¹«ÀÏ
    ±¸¿¬ (6)  »ý½Ä³»ºÐºñ,ºÎ½Å(I) 39-44
                  ÁÂÀå/ÁÂÀ庸-ÃÖµ¿¼·/ÀÌÇü¿ì
    10:20-10:40 Coffee Break
    10:40-12:10 Symposium (4) ´ç´¢º´°ú ºñ¸¸
                  ÁÂÀå/ÁÂÀ庸-ÀÌÇöö/±èÅÂÈ­
    ´ç´¢º´°ú ºñ¸¸ÀÇ º´Å»ý¸®

    (1) ºñ¸¸°ú PPAR delta
    °­ÇåÁß (¼­¿ï´ë ÇØ¾ç»ý¸í°øÇаú)

    (2) Á¦2Çü ´ç´¢º´ º´Å»ý¸®
         (Àν¶¸° ÀúÇ×¼ºÀ» Áß½ÉÀ¸·Î)
    À̰ü¿ì (¾ÆÁÖÀÇ´ë)

    (3) 2Çü ´ç´¢º´ º´Å»ý¸®
         (Àν¶¸° °áÇÌÀ» Áß½ÉÀ¸·Î)
    ¾ÈÀ¯¹è (°¡Å縯ÀÇ´ë)
    Symposium (5) ³ëÈ­
                  ÁÂÀå/ÁÂÀ庸-Á¤¹Î¿µ/¹Ú¼º¿ì
    ³»ºÐºñÀû °üÁ¡¿¡¼­ ¹Ù¶óº» ³ëÈ­

    (1) Successful aging
    À¯ÇüÁØ (ÇѸ²ÀÇ´ë)

    (2) ³ëÀο¡¼­ È£¸£¸ó ´ëü¿ä¹ý :
         longevity vs QOL
    Á¤À±¼® (¾ÆÁÖÀÇ´ë)

    (3) ³ëÀο¡¼­ Ç׳ëÈ­(anti-aging)Á¦
         Ä¡·áÀÇ Çã¿Í ½Ç
    ³²È«¿ì (±¹¸³ÀÇ·á¿ø)
    12:10-13:20 Luncheon Lecture Viagra & Lipitor Luncheon symposium ( April 22 2005)
    12:10- 12:20IntroductionÃæ³²ÀÇ´ë ±è¿µ°Ç    
    12:20- 12:40Hyperlipidemiatreatment in diabetic patients¿¬¼¼ÀÇ´ë Á¶È«±Ù    
    12:40- 13:00"From Cell to Sex"the heart of successful EDtherapy for diabetes with ED°¡Å縯ÀÇ´ë ±è¼º·¡    
    13:00-13:10Q&A
    13:20-14:10 Plenary Lecture                                                                      ÁÂÀå-¼ÕÈ£¿µ
    Inhibition of adipogenesis by two secretory factors from adipose tissue : Pref-1 and ADSF/resistin
                                         Hei Sook Sul (University of California Berkeley, USA)
    14:10-15:00 Special Lecture                                                                      ÁÂÀå-°­¼º±¸
    Çѱ¹ÀÇ ÀÇ·áÁ¤Ä¡- ÀïÁ¡°ú Áö¹è±¸Á¶
                                                                                 ¼ÛÈ£±Ù (¼­¿ï´ë »çȸÇаú)
    15:00-16:30 Symposium (6) °©»ó¼±                                      ÁÂÀå/ÁÂÀ庸-±è±¤¿ø/¹ÚÁ¤¼ö
    °©»ó¼± °áÀýÀÇ Ä¡·á

    (1) Update of molecular pathogenesis in thyroid carcinoma
    À̰¡Èñ (¿øÀڷº´¿ø)

    (2) °©»ó¼± ¹Ì¼¼À¯µÎ¾Ï-¸ðµç ȯÀÚ¸¦ ¼ö¼úÇØ¾ß ÇÑ´Ù?
    °­È£Ã¶ (Àü³²ÀÇ´ë)

    (3) °©»ó¼± ¹Ì¼¼À¯µÎ¾Ï-¼±ÅÃÀûÀ¸·Î ¼ö¼úÇØ¾ß ÇÑ´Ù?
    ±èÇöÁø (À»ÁöÀÇ´ë)
    16:30-16:50 Coffee Break and Poster Session
    16:50-18:10 ±¸¿¬ (7)  °©»ó¼±(¥²) 45-52
                   ÁÂÀå/ÁÂÀ庸-±è°æ·¡/Á¤ÀçÈÆ
    ±¸¿¬ (8)  ºñ¸¸ ¹× ÁöÁú´ë»ç 53-59
                   ÁÂÀå/ÁÂÀ庸-±è¿ë¼º/±èÀÎÁÖ
    18:10-18:30 2005³â ¿¬±¸º»»ó ¹×  ŒÀº¿¬±¸ÀÚ»ó ½Ã»ó½Ä
    ¿ì¼ö¿¬Á¦ ½Ã»ó½Ä
    Closing Remark